Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review
Crohn’s disease and ulcerative colitis are the two most common categories of inflammatory bowel disease (IBD), which are characterized by chronic inflammation of the intestine that comprises the patients’ life quality and requires sustained pharmacological and surgical treatments. Since their aetiol...
Saved in:
| Main Authors: | Francesca Algieri, Alba Rodriguez-Nogales, M. Elena Rodriguez-Cabezas, Severiano Risco, M. Angeles Ocete, Julio Galvez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2015/179616 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic potential of botanical drugs and their metabolites in the treatment of pelvic inflammatory disease
by: Han-Zhi Zhong, et al.
Published: (2025-04-01) -
Classification of Nanomaterial Drug Delivery Systems for Inflammatory Bowel Disease
by: Wang H, et al.
Published: (2025-02-01) -
Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management
by: Kyeong-Ryoon Lee, et al.
Published: (2024-11-01) -
The Bowel Microbiota and Inflammatory Bowel Diseases
by: Gerald W. Tannock
Published: (2010-01-01) -
Bowel Urgency in Inflammatory Bowel Disease
by: Teodora SPATARU, et al.
Published: (2025-06-01)